venetoclax,ibrutinib,rituximab
abbvie,janssen
['lymphoma', 'rituximab', 'lymsm', 'venetoclax', 'cml', 'ritux', 'ibru']
congress|#17icml , summarizes the phase ii window-2 trial results on chemo-free induction with ibrutinib-rituximab-venetoclax (irv) followed by r-hypercvad/mtx in young pts with untreated mcl. irv induced deep responses and was safe
#lymsm #lymphoma 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm